Recent news on Granisetron

AP Pharma Reports Results for the First Quarter 2007  -  May 8, 2007
PharmaLive.com (press release),Our lead product candidate using our proprietary Biochronomer(TM) technology is APF530, which contains granisetron, a drug approved for the prevention of

China Pharma Holdings, Inc. Announces First Quarter 2007 Results  -  May 15, 2007
PharmaLive.com (press release),It has already received approval for granisetron hydrochloride which it plans to launch in the second half of 2007. Moreover, the company is benefiting from

China Pharma Holdings, Inc. Announces Record Fourth Quarter and ...  -  Mar 29, 2007
Drug Newswire (press release),In 2006, the Company received the Chinese State Food and Drug Administration (SFDA) approval to manufacture and market its granisetron hydrochloride

AP Pharma Reports Results for the Fourth Quarter and Full Year ...  -  Mar 7, 2007
PharmaLive.com (press release),APF530, which contains the 5HT3 antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery

Barr Receives Tentative Approval for Generic Kytril Tablets, 1mg ...  -  18 Jan 2007
PharmaLive.com (press release),KYTRIL (granisetron hydrochloride) Tablets, 1mg (base) is indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of

AP Pharma Resets APF530 NDA Filing Expectations  -  Dec 22, 2006
PipelineReview.com (press release),APF530, which contains the 5HT(3) antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug

TechMARK movers: ProStrakan rockets on drug trial  -  Dec 6, 2006
ShareCast,...patch prevented nausea and vomiting over the course of multi-day chemotherapy with efficacy comparable to repeat daily doses of oral granisetron.

AP Pharma Resets APF530 NDA Filing Expectations  -  Dec 22, 2006
PipelineReview.com (press release),APF530, which contains the 5HT(3) antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug

China Pharma Holdings, Inc. Receives Approval for Granisetron ...  Oct 9, 2006
...announced it had received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its Granisetron Hydrochloride Injection ... -PharmaLive.com (press release), China Pharma Holdings, Inc. Receives Approval for Granisetron ...  Oct 9, 2006
Granisetron hydrochloride is indicated for the prevention of nausea and vomiting associated with radiation treatment and chemotherapy in cancer patients. ... -Earthtimes.org AP Pharma Posts Wider Loss In Q3 - Update  Nov 7, 2006
APF530, which contains the 5HT3 antagonist anti-nausea drug granisetron is formulated with the company's proprietary Biochronomer bioerodible drug delivery ... -Trading Markets, AP Pharma Reports 2006 Third Quarter Results  Nov 7, 2006
APF530, which contains the 5HT3 antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery ... -PharmaLive.com (press release), (PRN) - The Delta Companies Announce a Move to Quadruple Office ...  Oct 9, 2006
...[+]. (PRN) - China Pharma Holdings, Inc. Receives Approval for Granisetron Hydrochloride Injection ... [+. PRN) - CNH Plant in Burlington Gets High Honor ... ... -Bolsamania.com, (PRN) - Zimbra Named a Finalist for the 'Next Big Thing' at ...  Oct 9, 2006
Friends ... [+. PRN) - China Pharma Holdings, Inc. Receives Approval for Granisetron Hydrochloride Injection ... [+. PRN) - Baltimore ... -Bolsamania.com, Drugs for Postoperative Nausea May Not Help Most Patients  Sep 21, 2006
...drugs found to reliably prevent nausea and vomiting after surgery, according to the review, are cyclizine, droperidol, granisetron, metoclopramide, ondansetron ... -Newstarget.com

SSRI-Associated Sexual Dysfunction  Aug 31, 2006
...did not find significant improvement in trials comparing bupropion and placebo, buspirone and placebo, granisetron and placebo, amantadine and placebo ... -Am J Psychiatry (subscription)

TechMARK movers: ProStrakan rockets on drug trial  -  Dec 6, 2006
ShareCast,...patch prevented nausea and vomiting over the course of multi-day chemotherapy with efficacy comparable to repeat daily doses of oral granisetron.

The Cochrane Library: news alert, Issue 3 - 2006  Aug 20, 2006
...considered, nine were most effective: Droperidol, Metoclopramide, Ondansetron, Tropisetron, Dolasetron, Dexamethasone, Cyclizine, Ramosetron and Granisetron. ... -Xagena.it

The Cochrane Library: news alert, Issue 2 - 2006  Aug 20, 2006
...chemotherapy. These include 5-HT receptor antagonists such as Dolasetron, Granisetron and Ondansetron as well as Dexamethasone. ... -Xagena.it

AP Pharma Reports 2006 Second Quarter Results; Phase 3 Clinical ...  Aug 8, 2006
...with the currently approved dose of palonosetron (brand name ALOXI(R)). APF530 contains the 5HT(3) antagonist anti-nausea drug granisetron formulated with the ... -Business Wire

Drugs for Postoperative Nausea May Not Help Most Patients  Jul 18, 2006
...drugs found to reliably prevent nausea and vomiting after surgery, according to the review, are cyclizine, droperidol, granisetron, metoclopramide, ondansetron ... -Health Behavior News Service

Drugs given to stop nausea and vomiting after surgery help only a ...  Jul 19, 2006
...considered, nine were most effective: droperidol, metoclopramide, ondansetron, tropisetron, dolasetron, dexamethasone, cyclizine, ramosetron and granisetron. ... -News-Medical.net



AP Pharma Reports 2006 First Quarter Results; Phase 3 Clinical ...  May 10, 2006
APF530 contains the 5HT(3) antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) drug delivery system. ... - Genetic Engineering News





Prevention of Postoperative Nausea and Vomiting with Granisetron ...  Mar 21, 2006
Hershey, PA. We investigated the efficacy of granisetron and dolasetron in preventing postoperative nausea and vomiting. Because ... - Anesthesia & Analgesia (subscription)

AP Pharma Reports 2005 Full Year and Fourth Quarter Results ...  Mar 15, 2006
APF530, which contains the anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery system, is being ... - Business Wire



ProStrakan gains US approval for chemotherapy anti-nausea patch  Feb 8, 2006
...chemotherapy. The Sancuso patches use the existing anti-emetic drug granisetron, and patients do not require daily injections or pills. ... - Scotsman

AP Pharma seeks approval for trial protocol  Jan 25, 2006
APF530 contains the anti-nausea drug granisetron formulated with the company's proprietary Biochronomer bioerodible drug delivery system. ... - Pharmaceutical Business Review

AP Pharma Announces Submission of APF530 Pivotal Trial Protocol ...  Jan 24, 2006
In each group, three sets of approximately 200 patients will be treated with APF530 containing 5 milligrams or 10 milligrams of granisetron, compared with the ... - Business Wire

AP Pharma Completes Financing for up to $30 Million; Sells Royalty ...  Jan 18, 2006
APF530, which contains the anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery system, is being ... - Genetic Engineering News

FDA Approves EMEND(R) (aprepitant), in Combination with Other ...  Jan 11, 2006
...clinical drug interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron, granisetron, or hydrodolasetron ... - Business Wire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional